Global Amprolium Hydrochloride API Market Size, Share and Analysis Report 2026-2032

The global Amprolium Hydrochloride API market size is predicted to grow from US$ 53.12 million in 2025 to US$ 103 million in 2032; it is expected to grow at a CAGR of 9.5% from 2026 to 2032.

Amprolium Hydrochloride API (Active Pharmaceutical Ingredient) is a white powder, a synthetic thiamine (Vitamin B1) analog used as a coccidiostat (anti-parasitic) in veterinary medicine, primarily for preventing and treating coccidiosis in poultry (chickens, turkeys) and livestock (calves, lambs) by blocking parasite energy metabolism, available as a feed additive or in water, and is known for its high safety margin and low toxicity.

In 2025, global production of amprolium hydrochloride reached 1,428 tons, with an average selling price of USD 38 per kilogram. The total global installed capacity is approximately 1,600 tons, and industry gross margins are typically between 30% and 40%. The cost structure consists of roughly 65% direct materials, 27% manufacturing and transportation expenses, and 8% labor. The industry chain includes upstream raw materials, mainly vitamin B1 intermediates, and downstream applications such as veterinary anticoccidial drugs, feed additives, and veterinary drug formulations.

United States market for Amprolium Hydrochloride API is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Amprolium Hydrochloride API is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Amprolium Hydrochloride API is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Amprolium Hydrochloride API players cover Phibro Animal Health, Zhejiang Dayang Biology Technology, Kaifeng Darui Pharmaceutical, Jinan Shangyuan New Materials, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

Infinity Market Research newest research report, the ?Amprolium Hydrochloride API Industry Forecast? looks at past sales and reviews total world Amprolium Hydrochloride API sales in 2025, providing a comprehensive analysis by region and market sector of projected Amprolium Hydrochloride API sales for 2026 through 2032. With Amprolium Hydrochloride API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Amprolium Hydrochloride API industry.

This Insight Report provides a comprehensive analysis of the global Amprolium Hydrochloride API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Amprolium Hydrochloride API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Amprolium Hydrochloride API market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Amprolium Hydrochloride API and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Amprolium Hydrochloride API.

This report presents a comprehensive overview, market shares, and growth opportunities of Amprolium Hydrochloride API market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    Content 98%
    Content 99%
    Segmentation by Grade:
    Industrial Grade
    Veterinary Drug Grade

Segmentation by Application:

    Poultry
    Cattle and Sheep
    Others

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.

    Phibro Animal Health
    Zhejiang Dayang Biology Technology
    Kaifeng Darui Pharmaceutical
    Jinan Shangyuan New Materials

Key Questions Addressed in this Report

What is the 10-year outlook for the global Amprolium Hydrochloride API market?
What factors are driving Amprolium Hydrochloride API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Amprolium Hydrochloride API market opportunities vary by end market size?
How does Amprolium Hydrochloride API break out by Type, by Application?